These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12917967)

  • 61. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
    Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH
    Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2001; (1):CD002024. PubMed ID: 11279747
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance.
    Awgu E; Magura S; Rosenblum A
    J Psychoactive Drugs; 2010 Sep; 42(3):339-46. PubMed ID: 21053756
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia.
    Ritter AJ; Lintzeris N; Clark N; Kutin JJ; Bammer G; Panjari M
    Addiction; 2003 Nov; 98(11):1605-13. PubMed ID: 14616187
    [TBL] [Abstract][Full Text] [Related]  

  • 65. QTc interval screening for cardiac risk in methadone treatment of opioid dependence.
    Pani PP; Trogu E; Maremmani I; Pacini M
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008939. PubMed ID: 23787716
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review.
    F Martins ML; Wilthagen EA; Oviedo-Joekes E; Beijnen JH; de Grave N; Uchtenhagen A; Beck T; Van den Brink W; Schinkel AH
    Drug Alcohol Depend; 2021 Oct; 227():108984. PubMed ID: 34482044
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral naltrexone maintenance treatment for opioid dependence.
    Minozzi S; Amato L; Vecchi S; Davoli M; Kirchmayer U; Verster A
    Cochrane Database Syst Rev; 2011 Feb; (2):CD001333. PubMed ID: 21328250
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Street-level drug law enforcement and entry into methadone maintenance treatment.
    Weatherburn D; Lind B
    Addiction; 2001 Apr; 96(4):577-87. PubMed ID: 11300961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review.
    McNair R; Monaghan M; Montgomery P
    Drug Alcohol Depend; 2023 Jun; 247():109869. PubMed ID: 37086659
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diacetylmorphine versus methadone for the treatment of opioid addiction.
    Oviedo-Joekes E; Brissette S; Marsh DC; Lauzon P; Guh D; Anis A; Schechter MT
    N Engl J Med; 2009 Aug; 361(8):777-86. PubMed ID: 19692689
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Naltrexone maintenance treatment for opioid dependence.
    Kirchmayer U; Davoli M; Verster A
    Cochrane Database Syst Rev; 2002; (2):CD001333. PubMed ID: 12076406
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dopamine agonists for cocaine dependence.
    Soares BG; Lima MS; Reisser AA; Farrell M
    Cochrane Database Syst Rev; 2001; (4):CD003352. PubMed ID: 11687193
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Naltrexone maintenance treatment for opioid dependence.
    Kirchmayer U; Davoli M; Verster A
    Cochrane Database Syst Rev; 2001; (4):CD001333. PubMed ID: 11687108
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship between LAAM-methadone preference and treatment outcomes.
    White JM; Danz C; Kneebone J; La Vincente SF; Newcombe DA; Ali RL
    Drug Alcohol Depend; 2002 May; 66(3):295-301. PubMed ID: 12062464
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Time of day of methadone consumption and illicit heroin use.
    Best D; Gossop M; Marsden J; Farrell M; Strang J
    Drug Alcohol Depend; 1997 Dec; 49(1):49-54. PubMed ID: 9476699
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Appropriateness of methadone maintenance treatment for opiate addiction: evaluation by an expert panel.
    Vader JP; Hämmig R; Besson J; Eastus C; Eggenberger C; Burnand B
    Soz Praventivmed; 2003; 48 Suppl 1():S1-14. PubMed ID: 12891872
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against.
    Epstein DH; Preston KL
    Addiction; 2003 Mar; 98(3):269-79. PubMed ID: 12603227
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments.
    Perneger TV; Giner F; del Rio M; Mino A
    BMJ; 1998 Jul; 317(7150):13-8. PubMed ID: 9651260
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The heroin prescribing debate: integrating science and politics.
    Bammer G; Dobler-Mikola A; Fleming PM; Strang J; Uchtenhagen A
    Science; 1999 May; 284(5418):1277-8. PubMed ID: 10383306
    [No Abstract]   [Full Text] [Related]  

  • 80. Naltrexone maintenance treatment for opioid dependence.
    Kirchmayer U; Davoli M; Verster A
    Cochrane Database Syst Rev; 2003; (2):CD001333. PubMed ID: 12804405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.